How structural changes are driving R&D activity in India’s pharmaceutical sector
- 13 June 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 14 (3) , 256-261
Abstract
Objectives: Rising Research and Development (R&D) activity has led to dramatic growth in India’s pharmaceutical market in the last decade. This increase in R&D was occurring at a time of significant changes in the sector, notably in the intellectual property rights (IPR) system and the sector’s increased focus on biopharmaceuticals. The objective of this study is to examine the impact of these structural changes along with the traditional drivers of R&D activity to better understand the transformation in India’s pharmaceutical sector during this period and shed light on its future trajectory. Method: We extend the traditional model to estimate the determinants of R&D by incorporating the changes in India’s pharmaceutical sector during this period. With pooled data for the top 16 pharmaceutical firms during the last decade, this model is estimated using feasible generalised least squares. Key findings: Our results show that R&D is affected by firm size, global reach, and profitability. Experience, particularly successful patent experience, is important. However, at some point, R&D activity resulting from longevity succumbs to diminishing returns. Also, the IPR environment and firm investment in biopharmaceutical treatment are important drivers of R&D. Conclusion: Promoting R&D activity is vital to keep India’s pharmaceutical sector on its growth trajectory. Policies supporting the sector’s shift from imitation to innovation and promotion of biopharmaceutical treatment will ensure its continued success.Keywords
This publication has 14 references indexed in Scilit:
- Pharma Success in Product Development—Does Biotechnology Change the Paradigm in Product Development and AttritionThe AAPS Journal, 2015
- The Determinants of Research and Development Investment in the Pharmaceutical Industry: Focus on Financial StructuresOsong Public Health and Research Perspectives, 2015
- The Effects of Future Capital Investment and R&D Expenditures on Firms' LiquidityReview of International Economics, 2013
- Determination of R&D investment in French firms: a two-part hierarchical model with correlated random effectsEconomics of Innovation and New Technology, 2010
- The Determinants of Pharmaceutical R&D Expenditures: Evidence from JapanReview of Industrial Organization, 2006
- The determinants of pharmaceutical research and development expendituresJournal of Evolutionary Economics, 2000
- R&D and Global Manufacturing PerformanceManagement Science, 1998
- Firm size, opportunities for adaptation and in-house R & D activity in developing countries: the case of Indian manufacturingResearch Policy, 1996
- FIRM SIZE AND IN‐HOUSE R & D: THE INDIAN EXPERIENCE REVISITEDThe Developing Economies, 1993
- IN‐HOUSE R&D, IMPORTED TECHNOLOGY, AND FIRM SIZE: LESSONS FROM INDIAN EXPERIENCEThe Developing Economies, 1988